$POAI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Predictive Oncology Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Predictive Oncology Inc.. Get notifications about new insider transactions in Predictive Oncology Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 23 2021 | POAI | Predictive Oncolog ... | Jenkins Christina Lee MD | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Apr 02 2021 | POAI | Predictive Oncolog ... | CHUNG-WELCH NANCY | Director | Grant | A | 0.00 | 4,959 | 0 | 9,657 | 4.7 K to 9.7 K (+105.56 %) |
Apr 02 2021 | POAI | Predictive Oncolog ... | HANDLEY DANIEL E | Director | Grant | A | 0.00 | 4,959 | 0 | 9,029 | 4.1 K to 9 K (+121.84 %) |
Apr 02 2021 | POAI | Predictive Oncolog ... | ENGLE J MELVILLE | CEO and Chairman | Grant | A | 0.00 | 4,959 | 0 | 9,029 | 4.1 K to 9 K (+121.84 %) |
Apr 02 2021 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Grant | A | 0.00 | 4,959 | 0 | 17,029 | 12.1 K to 17 K (+41.09 %) |
Apr 02 2021 | POAI | Predictive Oncolog ... | ST. CLAIR GREGORY SR | Director | Grant | A | 0.00 | 6,887 | 0 | 11,585 | 4.7 K to 11.6 K (+146.59 %) |
Apr 02 2021 | POAI | Predictive Oncolog ... | Nuzum Charles Lee Sr | Director | Grant | A | 0.00 | 6,887 | 0 | 13,599 | 6.7 K to 13.6 K (+102.61 %) |
Mar 12 2021 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Buy | J | 1.43 | 100,401 | 143,573 | 1,711,742 | 1.6 M to 1.7 M (+6.23 %) |
Jan 05 2021 | POAI | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Option Exercise | A | 0.73 | 47,788 | 35,000 | 47,788 | |
Jan 05 2021 | POAI | Predictive Oncolog ... | CHUNG-WELCH NANCY | Director | Option Exercise | A | 0.73 | 34,135 | 25,000 | 34,135 | |
Jan 05 2021 | POAI | Predictive Oncolog ... | HANDLEY DANIEL E | Director | Option Exercise | A | 0.73 | 20,481 | 15,000 | 20,481 | |
Oct 26 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Sell | S | 0.85 | 640 | 544 | 1,611,341 | 1.6 M to 1.6 M (-0.04 %) |
Oct 26 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Sell | S | 0.85 | 640 | 544 | 1,611,341 | 1.6 M to 1.6 M (-0.04 %) |
Oct 02 2020 | POAI | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Option Exercise | A | 0.81 | 6,142 | 5,000 | 6,142 | |
Oct 02 2020 | POAI | Predictive Oncolog ... | CHUNG-WELCH NANCY | Director | Option Exercise | A | 0.81 | 6,142 | 5,000 | 6,142 | |
Oct 02 2020 | POAI | Predictive Oncolog ... | Nuzum Charles Lee Sr | Director | Option Exercise | A | 0.81 | 6,142 | 5,000 | 6,142 | |
Oct 02 2020 | POAI | Predictive Oncolog ... | ST. CLAIR GREGORY SR | Director | Option Exercise | A | 0.81 | 6,142 | 5,000 | 6,142 | |
Oct 02 2020 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Option Exercise | A | 0.81 | 6,142 | 5,000 | 6,142 | |
Oct 02 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.81 | 6,142 | 5,000 | 6,142 | |
Sep 25 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Sep 25 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.00 | 300,000 | 0 | 300,000 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 16,600 | 25,564 | 16,600 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 7.48 | 16,600 | 124,168 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 30,411 | 46,833 | 30,411 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 14.70 | 30,411 | 447,042 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 357 | 550 | 357 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 41.98 | 357 | 14,985 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 14 | 22 | 14 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 4,312.50 | 14 | 60,375 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 42 | 65 | 42 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 1,481.25 | 42 | 62,213 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 53 | 82 | 53 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 1,500.00 | 53 | 79,500 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 6,050 | 9,317 | 6,050 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 5.51 | 6,050 | 33,336 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 5,128 | 7,897 | 5,128 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 6.50 | 5,128 | 33,332 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 4,219 | 6,497 | 4,219 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 7.90 | 4,219 | 33,330 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 20,000 | 30,800 | 20,000 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 7.48 | 20,000 | 149,600 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 59 | 91 | 59 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 42.50 | 59 | 2,508 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 133 | 205 | 133 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 37.50 | 133 | 4,988 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 121 | 186 | 121 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 41.25 | 121 | 4,991 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 179 | 276 | 179 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 28.00 | 179 | 5,012 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 238 | 367 | 238 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 21.00 | 238 | 4,998 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 7 | 11 | 7 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 2,812.50 | 7 | 19,688 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 32,305 | 49,750 | 32,305 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 6.19 | 32,305 | 200,000 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 4,490 | 6,915 | 4,490 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 11.60 | 4,490 | 52,084 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 12,168 | 18,739 | 12,168 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 11.30 | 12,168 | 137,498 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 14,178 | 21,834 | 14,178 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 9.70 | 14,178 | 137,527 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 2,834 | 4,364 | 2,834 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 14.70 | 2,834 | 41,660 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 37,691 | 58,044 | 37,691 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 14.70 | 37,691 | 554,058 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 714 | 1,100 | 714 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 28.00 | 714 | 19,992 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 52 | 80 | 52 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 775.00 | 52 | 40,300 | 0 | |
Sep 02 2020 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Buy | P | 0.90 | 4,000 | 3,602 | 12,070 | 8.1 K to 12.1 K (+49.57 %) |
Sep 02 2020 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Buy | P | 0.90 | 4,000 | 3,602 | 12,070 | 8.1 K to 12.1 K (+49.57 %) |
Aug 21 2020 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Buy | P | 1.18 | 2,610 | 3,067 | 8,070 | 5.5 K to 8.1 K (+47.80 %) |
Aug 21 2020 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Buy | P | 1.18 | 390 | 460 | 5,460 | 5.1 K to 5.5 K (+7.69 %) |
Jul 14 2020 | POAI | Predictive Oncolog ... | ST. CLAIR GREGORY SR | Director | Grant | A | 0.00 | 4,698 | 0 | 4,698 | 0 to 4.7 K |
Jul 14 2020 | POAI | Predictive Oncolog ... | ST. CLAIR GREGORY SR | Director | Grant | A | 0.00 | 4,698 | 0 | 4,698 | 0 to 4.7 K |
Jul 13 2020 | POAI | Predictive Oncolog ... | Nuzum Charles Lee Sr | Director | Grant | A | 0.00 | 6,712 | 0 | 6,712 | 0 to 6.7 K |
Jul 13 2020 | POAI | Predictive Oncolog ... | CHUNG-WELCH NANCY | Director | Grant | A | 0.00 | 4,698 | 0 | 4,698 | 0 to 4.7 K |
Jul 02 2020 | POAI | Predictive Oncolog ... | Reding Andrew P. | Director | Option Exercise | A | 1.64 | 3,049 | 5,000 | 3,049 | |
Jul 02 2020 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Option Exercise | A | 1.64 | 3,049 | 5,000 | 3,049 | |
Jul 02 2020 | POAI | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Option Exercise | A | 1.64 | 3,049 | 5,000 | 3,049 | |
Jul 02 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.64 | 3,049 | 5,000 | 3,049 | |
Jul 02 2020 | POAI | Predictive Oncolog ... | HANDLEY DANIEL E | Director | Option Exercise | A | 1.64 | 3,049 | 5,000 | 3,049 | |
Jun 19 2020 | POAI | Predictive Oncolog ... | Reding Andrew P. | Director | Grant | A | 0.00 | 4,070 | 0 | 4,076 | 6 to 4.1 K (+67,833.33 %) |
Jun 19 2020 | POAI | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Grant | A | 0.00 | 4,070 | 0 | 4,070 | 0 to 4.1 K |
Jun 19 2020 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Grant | A | 0.00 | 4,070 | 0 | 5,070 | 1,000 to 5.1 K (+407.00 %) |
Jun 19 2020 | POAI | Predictive Oncolog ... | HANDLEY DANIEL E | Director | Grant | A | 0.00 | 4,070 | 0 | 4,070 | 0 to 4.1 K |
Jun 19 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Grant | A | 0.00 | 4,070 | 0 | 1,611,981 | 1.6 M to 1.6 M (+0.25 %) |
May 04 2020 | POAI | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Option Exercise | A | 1.31 | 15,267 | 20,000 | 15,267 | |
Apr 23 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Grant | A | 1.43 | 1,533,481 | 2,192,878 | 1,607,911 | 74.4 K to 1.6 M (+2,060.30 %) |
Apr 23 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Grant | A | 1.43 | 1,533,481 | 2,192,878 | 1,607,911 | 74.4 K to 1.6 M (+2,060.30 %) |
Apr 06 2020 | POAI | Predictive Oncolog ... | Vardzel Gerald J Jr | Director | Option Exercise | C | 0.00 | 62,843 | 0 | 0 | |
Apr 06 2020 | POAI | Predictive Oncolog ... | Vardzel Gerald J Jr | Director | Option Exercise | A | 1.58 | 3,174 | 5,000 | 3,174 | |
Apr 06 2020 | POAI | Predictive Oncolog ... | Vardzel Gerald J Jr | Director | Buy | C | 0.00 | 62,843 | 0 | 154,415 | 91.6 K to 154.4 K (+68.63 %) |
Apr 06 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.58 | 3,174 | 5,000 | 3,174 | |
Apr 02 2020 | POAI | Predictive Oncolog ... | Reding Andrew P. | Director | Option Exercise | A | 1.58 | 3,174 | 5,000 | 3,174 | |
Apr 02 2020 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Option Exercise | A | 1.58 | 3,174 | 5,000 | 3,174 | |
Apr 02 2020 | POAI | Predictive Oncolog ... | PRIOR PAMELA S | Director | Option Exercise | A | 1.58 | 3,174 | 5,000 | 3,174 | |
Apr 02 2020 | POAI | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Option Exercise | A | 1.58 | 3,174 | 5,000 | 3,174 | |
Jan 03 2020 | AIPT | Predictive Oncolog ... | Reding Andrew P. | Director | Option Exercise | A | 2.61 | 5,747 | 15,000 | 5,747 | |
Jan 03 2020 | AIPT | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Option Exercise | A | 2.61 | 13,410 | 35,000 | 13,410 | |
Jan 03 2020 | AIPT | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Option Exercise | A | 2.61 | 5,747 | 15,000 | 5,747 | |
Jan 03 2020 | AIPT | Predictive Oncolog ... | McGoldrick Thomas J. | Director | Option Exercise | A | 2.61 | 13,410 | 35,000 | 13,410 | |
Jan 03 2020 | AIPT | Predictive Oncolog ... | McGoldrick Thomas J. | Director | Option Exercise | A | 5.05 | 990 | 5,000 | 990 | |
Oct 03 2019 | AIPT | Predictive Oncolog ... | Reding Andrew P. | Director | Option Exercise | A | 0.51 | 9,900 | 5,000 | 9,900 | |
Oct 03 2019 | AIPT | Predictive Oncolog ... | KROCHUK TIMOTHY A | Director | Option Exercise | A | 0.51 | 9,900 | 5,000 | 9,900 | |
Oct 03 2019 | AIPT | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Option Exercise | A | 0.51 | 9,900 | 5,000 | 9,900 | |
Oct 03 2019 | AIPT | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Option Exercise | A | 0.51 | 9,900 | 5,000 | 9,900 | |
Oct 03 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.55 | 60,496 | 33,333 | 60,496 | |
Oct 03 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,205,923 | |
Oct 03 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,194,417 | |
Sep 18 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.55 | 60,496 | 33,333 | 60,496 | |
Sep 18 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,194,417 | |
Sep 06 2019 | AIPT | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Buy | P | 0.46 | 2,000 | 920 | 10,000 | 8 K to 10 K (+25.00 %) |
Aug 26 2019 | AIPT | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Buy | P | 0.62 | 800 | 496 | 8,000 | 7.2 K to 8 K (+11.11 %) |
Aug 26 2019 | AIPT | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Buy | P | 0.59 | 2,200 | 1,298 | 7,200 | 5 K to 7.2 K (+44.00 %) |
Aug 15 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,276,387 | |
Aug 15 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.65 | 51,282 | 33,333 | 1,264,481 | |
Aug 15 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.79 | 42,194 | 33,333 | 1,213,599 | |
Jul 03 2019 | AIPT | Predictive Oncolog ... | Reding Andrew P. | Director | Option Exercise | A | 0.75 | 6,689 | 5,000 | 6,689 | |
Jul 03 2019 | AIPT | Predictive Oncolog ... | McGoldrick Thomas J. | Director | Option Exercise | A | 0.75 | 6,689 | 5,000 | 6,689 | |
Jul 03 2019 | AIPT | Predictive Oncolog ... | KROCHUK TIMOTHY A | Director | Option Exercise | A | 0.75 | 6,689 | 5,000 | 6,689 | |
Jul 02 2019 | AIPT | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Option Exercise | A | 0.75 | 6,689 | 5,000 | 6,689 | |
Jul 02 2019 | AIPT | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Option Exercise | A | 0.75 | 6,689 | 5,000 | 6,689 | |
Jul 02 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,171,405 | |
Jun 04 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,159,899 | |
May 28 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Buy | P | 0.55 | 48,332 | 26,689 | 244,298 | 196 K to 244.3 K (+24.66 %) |
May 28 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Buy | P | 0.56 | 51,668 | 29,099 | 195,966 | 144.3 K to 196 K (+35.81 %) |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,148,393 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 1,136,887 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 1,131,608 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 1.19 | 138,889 | 165,000 | 1,126,329 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 987,440 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,148,393 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 1,136,887 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 1,131,608 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 1.19 | 138,889 | 165,000 | 1,126,329 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 987,440 | |
Apr 08 2019 | AIPT | Precision Therapeu ... | Reding Andrew P. | Director | Option Exercise | A | 0.75 | 125,000 | 93,500 | 125,000 | |
Apr 08 2019 | AIPT | Precision Therapeu ... | KROCHUK TIMOTHY A | Director | Option Exercise | A | 0.75 | 125,000 | 93,500 | 125,000 | |
Apr 08 2019 | AIPT | Precision Therapeu ... | KROCHUK TIMOTHY A | Director | Option Exercise | A | 0.75 | 125,000 | 93,500 | 125,000 | |
Apr 08 2019 | AIPT | Precision Therapeu ... | McGoldrick Thomas J. | Director | Option Exercise | A | 0.75 | 125,000 | 93,500 | 125,000 | |
Apr 08 2019 | AIPT | Precision Therapeu ... | Vardzel Gerald J Jr | Director | Option Exercise | A | 0.75 | 151,260 | 113,142 | 151,260 | |
Apr 08 2019 | AIPT | Precision Therapeu ... | Vardzel Gerald J Jr | Director | Buy | J | 0.00 | 197,506 | 0 | 197,506 | 0 to 197.5 K |
Apr 08 2019 | AIPT | Precision Therapeu ... | Vardzel Gerald J Jr | Director | Grant | A | 0.00 | 718,205 | 0 | 718,205 | 0 to 718.2 K |
Apr 08 2019 | AIPT | Precision Therapeu ... | GABRIEL RICHARD L | Director | Option Exercise | A | 0.75 | 125,000 | 93,500 | 125,000 | |
Apr 08 2019 | AIPT | Precision Therapeu ... | ENGLE J MELVILLE | Director | Option Exercise | A | 0.75 | 125,000 | 93,500 | 125,000 | |
Apr 08 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.75 | 200,000 | 149,600 | 200,000 | |
Apr 08 2019 | AIPT | Precision Therapeu ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 0.75 | 166,000 | 124,168 | 166,000 | |
Apr 03 2019 | AIPT | Precision Therapeu ... | GABRIEL RICHARD L | Director | Option Exercise | A | 0.75 | 6,667 | 5,000 | 6,667 | |
Apr 03 2019 | AIPT | Precision Therapeu ... | McGoldrick Thomas J. | Director | Option Exercise | A | 0.75 | 6,667 | 5,000 | 6,667 |